Glaukos (GKOS) EBT Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 3,350.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,350.00 |
| Dec 31, 2025 | -5,809.00 |
| Sep 30, 2025 | 2,637.00 |
| Jun 30, 2025 | 4,716.00 |
| Mar 31, 2025 | -2,513.00 |
| Dec 31, 2024 | 14,142.00 |
| Sep 30, 2024 | -3,057.00 |
| Jun 30, 2024 | -3,036.00 |
| Mar 31, 2024 | -2,344.00 |
| Dec 31, 2023 | 14,218.00 |
| Sep 30, 2023 | -1,330.00 |
| Jun 30, 2023 | 10,954.00 |
| Mar 31, 2023 | 5,219.00 |
| Dec 31, 2022 | 14,339.00 |
| Sep 30, 2022 | -1,558.00 |
| Jun 30, 2022 | -5,215.00 |
| Mar 31, 2022 | 1,068.00 |
| Dec 31, 2021 | -3,750.00 |
| Sep 30, 2021 | 2,360.00 |
| Jun 30, 2021 | -964.00 |
| Mar 31, 2021 | -1,708.00 |
| Dec 31, 2020 | -2,129.00 |
| Sep 30, 2020 | -2,907.00 |
| Jun 30, 2020 | -14,187.00 |
| Mar 31, 2020 | -10,110.00 |
| Dec 31, 2019 | -6,807.00 |
| Sep 30, 2019 | -2,716.00 |
| Jun 30, 2019 | -1,881.00 |
| Mar 31, 2019 | -614.00 |
| Dec 31, 2018 | -16,585.00 |
| Sep 30, 2018 | -417.00 |
| Jun 30, 2018 | 17,064.00 |
| Mar 31, 2018 | 323.00 |
| Dec 31, 2017 | 3,299.00 |
| Sep 30, 2017 | 1,962.00 |
| Jun 30, 2017 | 1,453.00 |
| Mar 31, 2017 | 5,140.00 |